FIP-WHO session - Health promotion: role of pharmacists

Thursday 1 October 2015
E16, 3 hours

Organised by the FIP Bureau 


Health promotion has been defined by the World Health Organization as the process of enabling people to increase control over, and to improve, their health. It moves beyond a focus on individual behaviour towards a wide range of social and environmental interventions. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services require pharmacists to develop and/or use educational materials for health promotion and disease prevention programmes that are applicable to a wide range of patient populations, age groups and health literacy levels. This session will show a global WHO prospective on the role of pharmacists in health promotion, as well as examples of initiatives taken by pharmacists associations or pharmacists in daily practice.  


Learning objectives

At the conclusion of this knowledge-based session, participants will be able to:

1.       Explain what is health promotion expected by society from community pharmacy;

2.       Describe the importance of advocacy of the role of pharmacists in health promotion

3.       Outline case-examples of national health promotion activities by national pharmacists’  organisations;

4.       Outline case-examples of health promotion in daily practice from different countries.

Chair: Sabine Kopp (WHO, Switzerland)



14:30 1) Introduction by the Chair

14:35 2) Health promotion: a global perspective on the role of pharmacists

Kwok-Cho Tang (WHO) 

15:05 3) Health promotion: example of national association taking the lead  

a) Health promotion campaigns by Japan Pharmaceutical Association

Nobuo Yamamoto (Japanese Pharmaceutical Association, Japan) 

b) Health promotion campaigns by Association of Danish Pharmacies

Birthe Søndergaard (Association of Danish Pharmacies, Denmark)

15:55 Break

16:15 3) Health promotion in daily practice: example of a community pharmacy 

Peter Guthrey (FIP CPS, Australia)

16:55 4) Panel discussion